This work is licensed under a
Creative Commons Attribution 4.0 International License
Neu, H.C. The Crisis in Antiboitic Resistance. Science, 1992, 257(5073), 1064-1072.
Opar, A. Bad Bugs Needs more Drugs. Nat. Rev. Drug Discovery, 2007, 6(12), 943-944.
Anderson, A. C; Schiffer, C; Pollastri, M and Peet, N.P. The challenge of developing robust drugs to overcome resistance. Drug Discovery Today, 2011, 16(17-18), 755-761.
Todd, B. Beyond MRSA: VISA and VRSA: what will ward off these pathogens in health care facilities? Am. J. Nurs., 2006, 106(4), 28-30.
Moffett, R.B. Central nervous system depressants VII. Pyridyl coumarins. J. Med. Chem., 1964, 7, 446-449.
Garazd, Y. L; Kornienko, E. M; Maloshtan; L. N; Garazd, M. M; Khilya, V.P. Modified coumarins. 17. Synthesis and anticoagulant activity of 3, 4-cycloannelated coumarin D- glycopyranosides. Chem. Nat. Prod., 2005, 41, 508-512.
Sreenivasulu, B; Sundaramurthy, V; Subba Rao, N.V. Search for physiologically active compounds. Part XXIII. Synthesis of 3-(3-pyridyl) and 3-(3-pyridyl)-4-methyl coumarins. Proc. Indian. Acad. Sci. A, 1974, 79, 41-48.
Moffett, R. B. Pyridylcoumarins. U. S. Patent, 3, 201, 406, (1965).
Matos, M. J; Vilar, Gonzalez-Franco, R. M; Uriarte, E; Santana, L; Friedman, C; Tatonetti, N. P; Viña, D and Fontenla, J.A. Novel (coumarin-3-yl)carbamates as selective MAO-B inhibitors: Synthesis, in vitro and in vivo assays, theoretical evaluation of ADME properties and docking study. Eur. J. Med. Chem., 2013, 63, 151-161.
Lad, H. B; Giri, R. R and Brahmbhatt, D.I. An efficient synthesis of some new 3- bipyridinyl substituted coumarins as potent antimicrobial agents. Chin. Chem. Lett., 2013, 24, 227-229.
Bhila, V. G; Patel, C. V; Brahmbhatt, D.I. One pot synthesis of some novel coumarins containing 5-(substituted-2-hydroxybenzoyl) pyridine as a new class of antimicrobial and antituberculosis agents. Med. Chem . Res., 2013, 22(9), 4338-4346.
Shimizu, T; Nozawa, T; Hatano, M. Magnetic circular dichroism studies of pyridine- heme complexes in aqueous media. Bioinorg. Chem., 1976, 6(2), 119-131.
Jia, J; Hubberstey, P; Champness, N. R and Schröder, M. In: Molecular Networks (Struct Bond); Mir Wais Hosseini, Ed.; Springer: Verlag Berlin Heidelberg, 2009; Vol. 132, pp.135-161.
Fraser, C. L and Smith, A.P. Metal complexes with polymeric ligands: Chelation and metalloinitiation approaches to metal tris(bipyridine) containing materials. J. Polym. Sci., Part A: Polym. Chem., 2000, 38(S1), 4704-4716.
Mongin, F; Trécourt, F; Gervais, B; Mongin, O; Quéguiner, G. First Synthesis of Caerulomycin B. A New Synthesis of Caerulomycin C. J. Org. Chem., 2002, 67, 3272-3276.
El-Kemary, M; Organero, J. A; Douhal, A. Fast Relaxation Dynamics of the Cardiotonic Drug Milrinone in Water Solutions. J. Med. Chem., 2006, 49(11), 3086-3091.
Patel, M. N; Dosi, P. A; Bhatt, B.S. Square planar palladium (II) complexes of bipyridines: synthesis, characterization and biological studies. J. Coord. Chem., 2012, 65(21), 3833-3844.
Patel, M. N; Parmar, P. A; Gandhi, D.S. DNA interactions and cytotoxic studies of cis- platin analogues of substituted 2, 2-bipyridines, Spectrochim. Acta., 2012, 97C, 54-59.
Dai, H; Yu, H; Liu, J; Li, Y; Qin, X; Zhang, X; Qin, Z; Wang, T; Fang, J. Synthesis and bioactivities of novel trifluoromethylated pyrazole oxime ether derivatives containing a pyridyl moiety. Arkivoc., 2009(vii), 126-142.
Johns, B. A; Gudmundsson, K. A; Allen, S.H. Pyrazolo[1, 5-a]pyridine antiherpetics: Effects of the C3 substituent on antiviral activity. Bioorg. Med. Chem. Lett., 2007, 17(10), 2858-2862.
Robertson, D. W; Krushinski, J. H; Pollock, G. D; Haye, J.S. Imidazole-pyridine bioisosterism: comparison of the inotropic activities of pyridine- and imidazole- substituted 6-phenyldihydropyridazinone cardiotonics. J. Med. Chem., 1988, 31, 461-465.
Thomas, K. D; Adhikari, A. V; Shetty, N.S. Design, synthesis and antimicrobial activities of some new quinoline derivatives carrying 1, 2, 3-triazole moiety. Eur. J. Med. Chem., 2010, 45(9), 3803-3810.
Krohnke, F. The specific synthesis of pyridines and oligopyridines, Synthesis, 1976, 1, 1-24.
NCCLS (National Committee for Clinical Laboratory Standards), Performance Standards for Antimicrobial Susceptibility Testing: Twelfth Informational Supplement. 2002, 1-56238-454-6, M100-S12 (M7).
Biscler, A. Ueber die entstehung einiger substituirter indole. Chem Ber., 1892, 25, 2860-2879.
Kira, M. A; Abdel-Raeman, M. O; Gadalla, K.Z. The vilsmeier-haack reaction - III Cyclization of hydrazones to pyrazoles. Tetrahedron. Lett., 1969, 10(2), 109-110.
Basnet, A.; Thapa, P.; Karki, R.; Na, Y.; Jhang, Y.; Jeong, B. S.; Jeong, T. C.; Lee, C. S.; Lee, E. S. 2, 4, 6-Trisubstituted pyridines: synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure-activity relationship. Bioorg. Med. Chem., 2007, 15(13), 4351-4359. ( Received 28 September 2014; accepted 08 October 2014 ).
[1] S. Pasricha, P. Gahlot, "Synthetic Strategies and Biological Potential of Coumarin-Chalcone Hybrids: A New Dimension to Drug Design", Current Organic Chemistry, Vol. 24, p. 402, 2020
DOI: https://doi.org/10.2174/1385272824666200219091830